265 related articles for article (PubMed ID: 19766698)
21. Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH.
Hieber L; Huber R; Bauer V; Schäffner Q; Braselmann H; Thomas G; Bogdanova T; Zitzelsberger H
J Biomed Biotechnol; 2011; 2011():693691. PubMed ID: 21436994
[TBL] [Abstract][Full Text] [Related]
22. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma.
Domingues R; Mendonça E; Sobrinho L; Bugalho MJ
Cytopathology; 2005 Feb; 16(1):27-31. PubMed ID: 15859312
[TBL] [Abstract][Full Text] [Related]
23. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells.
Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C
Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115
[TBL] [Abstract][Full Text] [Related]
24. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.
Lehman CE; Dillon LW; Nikiforov YE; Wang YH
Carcinogenesis; 2017 Mar; 38(3):293-301. PubMed ID: 28069693
[TBL] [Abstract][Full Text] [Related]
25. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
26. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
[TBL] [Abstract][Full Text] [Related]
27. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
28. RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
Santoro M; Melillo RM; Fusco A
Eur J Endocrinol; 2006 Nov; 155(5):645-53. PubMed ID: 17062879
[TBL] [Abstract][Full Text] [Related]
29. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers.
Motomura T; Nikiforov YE; Namba H; Ashizawa K; Nagataki S; Yamashita S; Fagin JA
Thyroid; 1998 Jun; 8(6):485-9. PubMed ID: 9669285
[TBL] [Abstract][Full Text] [Related]
30. RET/PTC rearrangement in thyroid tumors.
Nikiforov YE
Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746
[TBL] [Abstract][Full Text] [Related]
31. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia.
Sugg SL; Ezzat S; Rosen IB; Freeman JL; Asa SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):4116-22. PubMed ID: 9814501
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
Rabes HM; Klugbauer S
Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
[TBL] [Abstract][Full Text] [Related]
33. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
34. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Pierotti MA; Vigneri P; Bongarzone I
Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
[TBL] [Abstract][Full Text] [Related]
35. RET oncogene activation in papillary thyroid carcinoma.
Tallini G; Asa SL
Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
[TBL] [Abstract][Full Text] [Related]
36. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM
Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102
[TBL] [Abstract][Full Text] [Related]
38. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
39. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
40. Radiation induced thyroid cancer: fundamental and applied aspects.
Tronko M; Bogdanova T; Voskoboynyk L; Zurnadzhy L; Shpak V; Gulak L
Exp Oncol; 2010 Sep; 32(3):200-4. PubMed ID: 21403618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
